You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Citation Tools

Article menu

Download PDFPDF

XML
Clinical Care/Education/Nutrition
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dahlqvist S, Ahlén E, Filipsson K, et al
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
BMJ Open Diabetes Research and Care 2018;6:e000464. doi: 10.1136/bmjdrc-2017-000464